Sponsors (3)
The bill reduces public access to a high-risk chemical to lower poisoning risks—particularly for vulnerable consumers—while limiting impacts on foods and medical products, but it imposes short-term compliance costs on businesses and implementation strain on regulators.
Low-income consumers and the general public are protected from accidental or intentional poisoning because the bill bans consumer-distributed products containing ≥10% sodium nitrite, reducing availability of a high-risk substance.
Hospitals, health systems, and the broader food/medical supply chain are shielded from disruption because the bill explicitly exempts foods, drugs, and regulated meat/poultry/egg products from the ban.
Retailers and manufacturers, especially small businesses, will likely incur costs to remove, relabel, or reformulate products to comply with the ban, which could be passed on to consumers as higher prices.
State regulators and supply chains may face strain from the short 90‑day effective date, creating enforcement challenges and risk of temporary shortages or logistical disruptions.
Based on analysis of 2 sections of legislative text.
Prohibits consumer products that contain 10% or more sodium nitrite by weight, treating them as banned hazardous products under the CPSA, with specified exemptions.
Official title: To ban the sale of products with a high concentration of sodium nitrite to individuals, and for other purposes.
Introduced February 18, 2025 by Lori Trahan · Last progress April 30, 2025
Makes it illegal for consumer products sold or distributed for ordinary consumer use to contain a "high concentration" of sodium nitrite (defined as 10% or more by weight). The bill treats such products as "banned hazardous products" under the Consumer Product Safety Act, while excluding industrial/commercial supplies and items already regulated as food, drugs, devices, or cosmetics. The rule takes effect 90 days after the law is enacted.